Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 84,948 Shares

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 84,948 shares of the company’s stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of $70.02, for a total transaction of $5,948,058.96. Following the transaction, the chief executive officer now owns 5,208,057 shares of the company’s stock, valued at $364,668,151.14. This represents a 1.60 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Tempus AI Stock Up 6.8 %

TEM stock opened at $89.44 on Monday. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The firm has a 50 day simple moving average of $46.60 and a 200 day simple moving average of $50.37.

Wall Street Analyst Weigh In

Several equities research analysts have commented on TEM shares. Piper Sandler restated a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Bank of America raised their target price on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Guggenheim started coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price target for the company. Loop Capital lowered their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and upped their price objective for the stock from $45.00 to $65.00 in a report on Monday, November 11th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus price target of $58.55.

Institutional Investors Weigh In On Tempus AI

Institutional investors and hedge funds have recently modified their holdings of the stock. ARK Investment Management LLC raised its position in shares of Tempus AI by 132.1% during the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after purchasing an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its holdings in Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. raised its holdings in Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the period. Franklin Resources Inc. lifted its stake in Tempus AI by 240.5% during the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock valued at $93,251,000 after buying an additional 1,950,862 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in shares of Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock worth $55,836,000 after buying an additional 1,651,996 shares during the period. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.